Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.CSCI
Alternate Symbol(s):
CSCI
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CSCI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(7)
•••
archeo753
X
View Profile
View Bullboard History
Post by
archeo753
on Nov 11, 2024 2:45pm
Financial Results
Posted last year on Nov. 9. So should happen soon. Not expect much but at least we'll get an update. Whatever happened to the increased liquidity we were promised if Ceapro joined the
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Nov 09, 2024 8:15pm
CSCI Ai
BioVaxys Partner SpayVac for Wildlife, Inc., Scales-Up Vaccine Production Capacity
posted Nov 20, 2024 9:00am by
BioVaxys Technology Corp.
-
|
Kenneth Kovan, BioVaxys President & Chief Operating Officer, stated, "SpayVac for Wildlife, already a leader in developing breeding control, will leverage its scaled-up capacity to shorten the product-development cycle allowing them to further expand their pipeline using BioVaxys' technology platforms as engines for ...read more
(153)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Oct 31, 2024 1:23pm
Cosciens does not DISAPPOINT
In typical gagnon fashion the company/ies that he is at the control of continues to loose shareholder value, scientific presentation on Oct 8th another flop to add to the list of many, no updates at
...more
(153)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Oct 08, 2024 11:39am
RE:New Press Release - COSCIENS Biopharma Announces Change to Board of Directors
With gagnon leaving and not having someone to tell her what to do and say, it was inevitable that sweet Carolyn would jump the sinking ship. Was not a bad gig for the last 12 years, only do as gagnon
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Oct 08, 2024 8:10am
Perplexity Ai's Take:
Company Characteristics Revenue: Companies with six-member boards often have annual revenues in the range of $10 million to $100 million. Employees: Typically, these companies have between 50
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 08, 2024 7:30am
New Press Release - COSCIENS Biopharma Announces Change to Board of Directors
TORONTO, ONTARIO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today...
read article.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Oct 07, 2024 7:29pm
RE:RE:Tax-loss selling season:
The company just attracted a significant new director. This is a good sign. Who they get as the new President and CEO will tell a story as PGX is expected to reach the decision point for mass
...more
(13)
•••
jrsloan60
X
View Profile
View Bullboard History
Comment by
jrsloan60
on Oct 07, 2024 3:13pm
RE:Tax-loss selling season:
Thank you for the broker information. This company was not always a thinly traded company. It has just got worse and worse over the last 5 to 6 years massively. And it's really got bad in the last
...more
(13)
•••
jrsloan60
X
View Profile
View Bullboard History
Comment by
jrsloan60
on Oct 07, 2024 3:06pm
RE:Tax-loss selling season:
It doesn't matter when you sell them it for a loss. Yes it typically happens before the end of the year but all you have to do is not hold them for a month. In Canada but you can't even lock
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Oct 07, 2024 12:36pm
Tax-loss selling season:
Tax-loss selling typically occurs near the end of the calendar year in both Canada and the United States: Canada In Canada, tax-loss selling generally starts in November and continues until December
...more
(13)
•••
jrsloan60
X
View Profile
View Bullboard History
Comment by
jrsloan60
on Oct 07, 2024 12:31pm
RE:On Pierre Labbé's appointment to the Board of Directors:
This is why I bought the shares in the beginning cuz it looked like there were good guys on the board. But nothing has happened for many years. Went to the market once pumped it up to get $10 million.
...more
(153)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Oct 06, 2024 1:35pm
RE:New Director: Pierre Labbe
Does mean much when he is surrounded by spineless yes men/women
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Oct 06, 2024 9:37am
New Director: Pierre Labbe
Osisko Gold Royalties is a $4.7 billion market cap company: "Mr. Labb has been a director of Osisko Gold Royalties Ltd. a TSX- and NYSE-listed precious metal royalty company, since 2015, and
...more
(153)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Oct 05, 2024 8:27pm
RE:October 8 Abstract Presentation:
Well with the patent to expire shortly a lot of good the delayed off start up means little another example of gagnon's failure to live up to promises and deliver in a timely manner
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden